Colgate-Palmolive (NYSE:CL) Shares Purchased by Hollow Brook Wealth Management LLC

Hollow Brook Wealth Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL) by 5.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,200 shares of the company’s stock after buying an additional 200 shares during the period. Hollow Brook Wealth Management LLC’s holdings in Colgate-Palmolive were worth $436,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA increased its holdings in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after purchasing an additional 557,492 shares during the period. Legal & General Group Plc increased its stake in Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after buying an additional 61,413 shares during the period. FMR LLC raised its position in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after acquiring an additional 2,955,442 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Colgate-Palmolive by 0.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 4,595,245 shares of the company’s stock worth $477,032,000 after acquiring an additional 11,750 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on CL shares. UBS Group raised their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $96.63 on Monday. The stock has a market cap of $78.95 billion, a PE ratio of 27.69, a PEG ratio of 3.45 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s fifty day moving average is $97.38 and its 200 day moving average is $98.64.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.